This study allowed us to propose that cell stiffness could be a biomarker of melanoma progression in vitro, in vivo, and potentially in patients, linked to EMT-TF phenotype switching and Tspan8 expression regulation. This evidence concerns the gene TSPAN8 and melanoma.